Middle East & Africa Point of Care Diagnostics Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The Middle East & Africa Point of Care Diagnostics Market size is expected to reach US$ 3,524.0 Million by 2031 from US$ 1,670.9 Million in 2024. The market is estimated to record a CAGR of 11.3% from 2025 to 2031.

Executive Summary and Middle East & Africa Point of Care Diagnostics Market Analysis:

The POC diagnostics market in the Middle East & Africa is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of the Middle East & Africa. It is expected to see remarkable growth in the future years. The growth of this segment is essentially driven by increasing burdens of chronic and infectious diseases, such as diabetes, cancer, HIV, and cardiovascular disorders, that raise the demand for fast and accurate diagnostic tools. Governments across the region are actively supporting healthcare improvements through funding, public health programs, and the adoption of advanced diagnostic technologies. Furthermore, increasing investments in healthcare infrastructure and efforts toward expanding access to medical services in rural and underserved areas are driving market development. Growing awareness about the early detection of diseases and the integration of innovative, portable diagnostic devices are other factors contributing toward higher adoption of POC testing, strengthening the outlook for the market in the Middle East & Africa.

Middle East & Africa Point of Care Diagnostics Market: Strategic Insights

Middle East & Africa Point of Care Diagnostics Market Segmentation Analysis:

• By Product, the Middle East & Africa Point of Care Diagnostics Market is segmented into Glucose Monitoring, Infectious Disease Testing, Cardio metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor or Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others. Glucose Monitoring held the largest share of the market in 2024.
• By Glucose Monitoring, the Middle East & Africa Point of Care Diagnostics Market is segmented into Blood Glucose Meter, Lancet, and Strips. Strips held the largest share of the market in 2024.
• By Infectious Disease Testing, the Middle East & Africa Point of Care Diagnostics Market is segmented into HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others. Respiratory Infection Testing held the largest share of the market in 2024.
• By Cardio Metabolic Testing, the Middle East & Africa Point of Care Diagnostics Market is segmented into Cardiac Troponin (cTn) Test, Myoglobin Test, and Others. Cardiac Troponin (cTn) Test held the largest share of the market in 2024.
• By Purchase Mode, the Middle East & Africa Point of Care Diagnostics Market is segmented into OTC and Prescription. Prescription held the largest share of the market in 2024.
• By Sample, the Middle East & Africa Point of Care Diagnostics Market is segmented into Blood, Urine, and Others. Blood held the largest share of the market in 2024.
• By End User, the Middle East & Africa Point of Care Diagnostics Market is segmented into Healthcare Facilities, Homecare, and Others. Healthcare Facilities held the largest share of the market in 2024.
• By Healthcare Facilities, the Middle East & Africa Point of Care Diagnostics Market is segmented into Hospitals and Clinics, Diagnostic Centers, and Others. Diagnostic Centers held the largest share of the market in 2024.

Middle East & Africa Point of Care Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics

The Middle East & Africa Point of Care Diagnostics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Middle East & Africa Point of Care Diagnostics Market Outlook

The integration of AI and machine learning ML into diagnostic devices is transforming healthcare by enabling faster, more accurate, and personalized diagnostics outside traditional clinical settings. AI-powered POC devices are enhancing diagnostic capabilities, improving decision-making, and reducing human error. These devices utilize machine learning algorithms to analyze complex data from diagnostic tests, such as blood glucose levels, infections, and genetic markers, providing accurate results with high precision. Companies such as Abbott Laboratories have developed AI-driven POC devices for continuous glucose monitoring (CGM), which helps individuals with diabetes manage their condition effectively. The Freestyle Libre system, a leading product in this category, uses machine learning to offer personalized insights based on glucose trends and patterns, helping patients make informed decisions about their health. AI is also being incorporated into rapid COVID-19 testing kits, significantly reducing testing time and enabling quicker results at the point of care, thus enhancing the efficiency of managing infectious disease outbreaks.

The increasing partnerships among market players for the development of AI-based POC diagnostics are expected to contribute to their adoptionIn April 2025, Unilabs Middle East launched the Hologic Genius™ Digital Diagnostics System in the UAE. This is the first AI-powered digital cytology technology in the region. The system uses deep learning-based AI alongside advanced volumetric imaging to improve the speed and accuracy of cervical cancer diagnoses. The launch supports the UAE's national health goals, which aim to lower cervical cancer rates and enhance early detection. This development highlights the increasing role of AI in changing diagnostic practices throughout the Middle East.The increasing demand for AI-enabled POC diagnostics is rising, especially in emerging markets where access to traditional healthcare infrastructure is limited. AI's ability to improve diagnostic speed and accuracy, reduce healthcare costs, and enable better management of chronic conditions is poised to continue driving its adoption.

Middle East & Africa Point of Care Diagnostics Market Country Insights

By country, the Middle East & Africa Point of Care Diagnostics Market is segmented into South Africa, Saudi Arabia, the United Arab Emirates, and the Rest of Middle East & Africa. South Africa held the largest share in 2024.

The prevalence of cancer is increasing, and it is one of the primary causes of death, with a significant number of people who have cancer in South Africa. According to the WHO 2022 report, 111,321 new cancer cases and 64,547 cancer deaths were reported in the country. According to The Cancer Association of South Africa (CANSA), ~100,000 people in South Africa are diagnosed with cancer every year. Moreover, the prevalence of diabetes is increasing due to urbanization and the unhealthy lifestyle of the population of South Africa. According to the International Diabetes Federation, ~4.2 million people will be living with diabetes in 2021 in the country.

The implementation of strategic health programs by the government is also supporting the growth of the point of care diagnostics market in South Africa. National Health Insurance (NHI) is financing the population to get free services at the point of care in public as well as private quality-accredited health facilities. NHI, along with a quality improvement program for public health facilities, is working for a significant change in the healthcare system of South Africa.

Middle East & Africa Point of Care Diagnostics Market Company Profiles

Some of the key players operating in the market include Siemens AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Nova Biomedical Corporation, Polymer Technology Systems, Inc. (PTS), and Danaher Corp.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East & Africa Point of Care Diagnostics Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise